WXIBF
WUXI BIOLOGICS CAY NEW
stockOTC
wuxi biologics provides an open-access, integrated technology platform for biologics drug development. we are the only true service platform in the world offering end-to-end solutions to empower anyone to discover, develop and manufacture biologics from concept to commercial manufacturing. our single-source approach to biologics development saves our clients critical time and money. see below how our experience, capacities and quality make us a world leading (cdmo). experience wuxi biologics' leadership team consists of industry experts with 15-20 years of experience in biological drug development in the u.s./eu. while at wuxi this team has contributed to 1 bla and 66 worldwide inds in just 3 years! expertise wuxi biologics has over 170+ returnees from large pharma and small biotechs in the u.s./eu. these scientists cover all facets of drug development from discovery to manufacture of final drug product. capacity and capabilities we have strong technical capabilities and an open-access
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1M | 6.01 | 2026-09-11 | +24.63% | 2.545 |
| 3M | 4.60 | 2026-07-08 | +62.83% | -6.038 |
| 6M | 4.70 | 2026-04-23 | +59.36% | 4.486 |
| 1Y | 5.30 | 2025-10-08 | +41.32% | 2.228 |
| 2Y | 2.50 | 2024-10-02 | +199.60% | — |
| 5Y | 15.25 | 2021-10-07 | -50.88% | -0.449 |
WUXI BIOLOGICS CAY NEW (OTC:WXIBF) stock price today is $7.49, and today's volume is 5,659. WXIBF is up 10.635% today. The 30 day average volume is 17,592. WXIBF market cap is $31.11B with 4.15B shares outstanding.